The Predominance of Alternatively Activated Macrophages Following Challenge with Cell Wall Peptide-Polysaccharide After Prior Infection with Sporothrix schenckii

Mycopathologia

Volumn 176, Issue 1-2, 2013, Pages 57-65

  Alegranci, Pamela ^a   de Abreu Ribeiro, Livia Carolina ^a   Ferreira, Lucas Souza ^a   Negrini, Thais de Cássia ^a   Maia, Danielle Cardoso Geraldo ^a   Tansini, Aline ^a   Gonçalves, Amanda Costa ^a   Placeres, Marisa Campos Polesi ^a   Carlos, Iracilda Zeppone ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

CD206; Cell wall peptide polysaccharide; Interleukin, fungus; M2 macrophages; Sporothrix schenckii

Indexed keywords

FUNGUS ANTIGEN; PEPTIDE; POLYSACCHARIDE;

ANIMAL; ARTICLE; ASCITES FLUID; CELL WALL; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DISEASE MODEL; EXUDATE; IMMUNOLOGY; IMMUNOPHENOTYPING; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; SPOROTHRIX; SPOROTRICHOSIS;

ANIMALS; ANTIGENS, FUNGAL; ASCITIC FLUID; CELL WALL; DISEASE MODELS, ANIMAL; EXUDATES AND TRANSUDATES; IMMUNOPHENOTYPING; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; PEPTIDES; POLYSACCHARIDES; SPOROTHRIX; SPOROTRICHOSIS;

FUNGI; SPOROTHRIX SCHENCKII;

EID: 84881024968     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-013-9663-y     Document Type: Article

References (42)

1. Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol. 2007;25(2): 181-7.
2. Carlos IZ, Sassá MF, Sgarbi DBG, Placeres MCP, Maia DCG. Current research on the immune response to experimental sporotrichosis. Mycopathologia. 2009;168: 1-10.
3. Hardman S, Stephenson I, Jenkins DR, Wiselka MJ, Johnson EM. Disseminated Sporothrix schenckii in a patient with AIDS. J Infect. 2005;51(3): e73-7.
4. Galhardo MC, Silva MT, Lima MA, Nunes EP, Schettini LE, De Freitas RF, Paes RA, Neves ES, Do Valle AC. Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome. J Neurol Neurosurg Psychiatr. 2010;81(6): 696-9.
5. Romero-Cabello R, Bonifaz A, Romero-Feregrino R, Sanchez CJ, Linares Y, Zavala JT, Romero LC, Romero-Feregrino R, Vega JT. Disseminated sporotrichosis. BMJ Case Rep. 2011. doi: 10. 1136/bcr. 10. 2010. 3404.
6. Lloyd KO, Bitoon MA. Isolation and purification of a peptido-rhamnomannan from the yeast form of Sporothrix schenckii: structural and immunochemical studies. J Immunol. 1971;107: 663-71.
7. Castillo MC, Tapia FJ, Arciniegas E. Ultrastructural localization of specific surface antigens in the dimorphic fungus Sporothrix schenckii. J Med Vet Mycol. 1990;28(1): 91-4.
8. Nascimento RC, Espíndola NM, Castro RA, Teixeira PA, Loureiro Y, Penha CV, Lopes-Bezerra LM, Almeida SR. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol. 2008;38(11): 3080-9.
9. Lima OC, Figueiredo CC, Previato JO, Mendonca-Previato L, Morandi V, Lopes-Bezerra LM. Involvement of fungal cell wall components in adhesion of Sporothrix schenckii to human fibronectin. Infect Immun. 2001;69: 6874-80.
10. Charles PC, Weber KS, Cipriani B, Brosnan CF. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias. J Neuroimmunol. 1999;100(1-2): 64-73.
11. Lopes-Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis. Ann Br Acad Sci. 2006;78: 293-308.
12. Nascimento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol Med Microbiol. 2005;43: 241-7.
13. Fernandes GF, Dos Santos PO, Rodrigues AM, Sasaki AA, Burger E, de Camargo ZP. Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species. Virulence. 2013;4(3): 241-9.
14. Ruiz-Baca E, Mora-Montes HM, López-Romero E, Toriello C, Mojica-Marín V, Urtiz-Estrada N. 2D-immunoblotting analysis of Sporothrix schenckii cell wall. Mem Inst Oswaldo Cruz. 2011;106(2): 248-50.
15. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3: 23-35.
16. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25: 677-86.
17. Hao N, Lu M, Fan Y, Cao Y, Zhang Z, Yang S. Macrophages in Tumor Microenvironments and the Progression of Tumors. Clin Dev Immunol. 2012;2012: 11. 948098.
18. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Ann Rev Immunol. 2009;27: 451-83.
19. + T cells correlates with Th1/Th2 phenotype. J Immunol. 1998;160: 5347-54.
20. Loureiro-Penha CV, Lopez-Bezerra LM. Concanavalin A-binding cell wall antigens of Sporothrix schenckii: a serological study. Med Mycol. 2000;38: 1-7.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-75.
22. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids. Anal Biochem. 1982;126(1): 131-8.
23. Corraliza IM, Campo ML, Soler G, Modollel M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods. 1994;174: 231-5.
24. Rodriguez-Cerdeira C, Arenas R, Moreno-Coutino G, Vasques E, Fernandez R, Chang P. Systemic fungal infections in patients with human immunodeficiency vírus. Actas Dermosifilogr. 2012. doi: 10. 1016/j. ad. 2012. 06. 017.
25. Broz P, Monack DM. Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev. 2011;243(1): 174-90.
26. Carlos IZ, Sgarbi DB, Placeres MC. Host organism defense by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii. Mycopathologia. 1999;144(1): 9-14.
27. Carlos IZ, Sgarbi DB, Santos GC, Placeres MC. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand J Immunol. 2003;57(3): 214-20.
28. Sassá MF, Souza LF, Ribeiro LCA, Carlos IZ. Immune response against Sporothrix schenckii in TLR-4-deficient mice. Mycopathologia. 2012;174(1): 21-30.
29. Negrini TC, Ferreira LS, Alegranci P, Arthur RA, Sundfeld PP, Maia DGC, Spolidorio LC, Carlos IZ. Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol Invest. 2013;42(1): 36-48.
30. + T-cells are important in regulating macrophage polarization in C57BL/6 wild-type mice. Cellul Immunol. 2011;266: 180-6.
31. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol. 2010;88(6): 1157-62.
32. Maia DC, Sassá MF, Placeres MC, Carlos IZ. Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii. Mycopathologia. 2006;161(1): 11-9.
33. Der van Der Veen RC. Nitric oxide and T helper cell immunity. Int Immunopharmacol. 2001;1(8): 1491-500.
34. Nascimento FR, Calich VL, Rodríguez D, Russo M. Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J Immunol. 2002;168(9): 4593-600.
35. Angulo I, Jiménez-Díaz MB, García-Bustos JF, Gargallo D, De Las Heras FG, Muñoz-Fernández MA, Fresno M. Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production. Cell Immunol. 2002;218(1-2): 46-58.
36. Zhang CR, Lin JC, Xu WM, Li M, Ye HS, Cui WL, Lin Q. Interleukin-12 and interleukin-2 alone or in combination against the infection in invasive pulmonary aspergillosis mouse model. Mycoses. 2012;56(2): 117-22. doi: 10. 1111/j. 1439-0507. 2012. 02220. x.
37. Ruan S, Mckinley L, Zheng M, Rudner X, D'souza A, Kolls JK, Shellito JE. Interleukin-12 and host defense against murine Pneumocystis pneumonia. Infect Immun. 2008;76(5): 2130-7.
38. Bhatia S, Fei M, Yarlagadda M, Qi Z, Akira S, Saijo S, Iwakura Y, Rooijen N, Gibson GA, St Croix CM, Ray A, Ray P. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS ONE. 2011;6(1): e15943.
39. Kroetz DN, Deepe GS. The role of cytokines and chemokines in Histoplasma capsulatum infection. Cytokine. 2012;58(1): 112-7. doi: 10. 1016/j. cyto. 2011. 07. 430.
40. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol. 2001;2: 102-7.
41. Wong MM, Fish EN. Chemokines: attractive mediators of the immune response. Semin Immunol. 2003;15: 5-14.
42. Romani L, Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 2006;4(4): 183-9.